These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 33086678)
1. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Claveria-Cabello A; Colyn L; Arechederra M; Urman JM; Berasain C; Avila MA; Fernandez-Barrena MG Cells; 2020 Oct; 9(10):. PubMed ID: 33086678 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis. Chen PJ; Huang C; Meng XM; Li J Biochimie; 2015 Sep; 116():61-9. PubMed ID: 26116886 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis. Barcena-Varela M; Colyn L; Fernandez-Barrena MG Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117267 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis. El Taghdouini A; van Grunsven LA Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1397-1408. PubMed ID: 27762150 [TBL] [Abstract][Full Text] [Related]
5. Targeting epigenetic DNA and histone modifications to treat kidney disease. Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238 [TBL] [Abstract][Full Text] [Related]
6. Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms. Khan S; Ahirwar K; Jena G Epigenomics; 2016 Aug; 8(8):1087-101. PubMed ID: 27411759 [TBL] [Abstract][Full Text] [Related]
7. A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A. Zeybel M; Luli S; Sabater L; Hardy T; Oakley F; Leslie J; Page A; Moran Salvador E; Sharkey V; Tsukamoto H; Chu DCK; Singh US; Ponzoni M; Perri P; Di Paolo D; Mendivil EJ; Mann J; Mann DA Mol Ther; 2017 Jan; 25(1):218-231. PubMed ID: 28129116 [TBL] [Abstract][Full Text] [Related]
8. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation. Chistiakov DA; Orekhov AN; Bobryshev YV Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009 [TBL] [Abstract][Full Text] [Related]
9. Cathepsin H-Mediated Degradation of HDAC4 for Matrix Metalloproteinase Expression in Hepatic Stellate Cells: Implications of Epigenetic Suppression of Matrix Metalloproteinases in Fibrosis through Stabilization of Class IIa Histone Deacetylases. Yang Z; Liu Y; Qin L; Wu P; Xia Z; Luo M; Zeng Y; Tsukamoto H; Ju Z; Su D; Kang H; Xiao Z; Zheng S; Duan Z; Hu R; Wang Q; Pandol SJ; Han YP Am J Pathol; 2017 Apr; 187(4):781-797. PubMed ID: 28157489 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis. Zhao Q; Qin CY; Zhao ZH; Fan YC; Wang K Tohoku J Exp Med; 2013 Jan; 229(1):35-43. PubMed ID: 23238615 [TBL] [Abstract][Full Text] [Related]
11. Classical HDACs in the regulation of neuroinflammation. Dai Y; Wei T; Shen Z; Bei Y; Lin H; Dai H Neurochem Int; 2021 Nov; 150():105182. PubMed ID: 34509559 [TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cell-specific deletion of SIRT1 exacerbates liver fibrosis in mice. Li M; Hong W; Hao C; Li L; Xu H; Li P; Xu Y Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3202-3211. PubMed ID: 28919365 [TBL] [Abstract][Full Text] [Related]
13. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4. Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546 [TBL] [Abstract][Full Text] [Related]
14. [Epigenetics and liver fibrogenesis]. Zhang YQ; Guo JS Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):571-574. PubMed ID: 29056005 [TBL] [Abstract][Full Text] [Related]
16. Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis. Li X; Wu XQ; Xu T; Li XF; Yang Y; Li WX; Huang C; Meng XM; Li J Toxicol Appl Pharmacol; 2016 Sep; 306():58-68. PubMed ID: 27396813 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic therapy of cancer with histone deacetylase inhibitors. Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724 [TBL] [Abstract][Full Text] [Related]
18. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target]. Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229 [TBL] [Abstract][Full Text] [Related]
19. HDAC4 stimulates MRTF-A expression and drives fibrogenesis in hepatic stellate cells by targeting miR-206. Han X; Hao C; Li L; Li J; Fang M; Zheng Y; Lu J; Li P; Xu Y Oncotarget; 2017 Jul; 8(29):47586-47594. PubMed ID: 28548935 [TBL] [Abstract][Full Text] [Related]
20. Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-β signaling. Tian W; Fan Z; Li J; Hao C; Li M; Xu H; Wu X; Zhou B; Zhang L; Fang M; Xu Y Int J Biochem Cell Biol; 2016 Feb; 71():35-43. PubMed ID: 26693892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]